Omeprazol Medical Valley Magasýruþolið hart hylki 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omeprazol medical valley magasýruþolið hart hylki 20 mg

medical valley invest ab - omeprazolum inn - magasýruþolið hart hylki - 20 mg

Omeprazol Medical Valley Magasýruþolið hart hylki 40 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

omeprazol medical valley magasýruþolið hart hylki 40 mg

medical valley invest ab - omeprazolum inn - magasýruþolið hart hylki - 40 mg

PEDIPPI Mixtúruduft, dreifa 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

pedippi mixtúruduft, dreifa 2 mg/ml

oresund pharma aps - omeprazolum inn - mixtúruduft, dreifa - 2 mg/ml

Flúoróúracil Accord Stungulyf/innrennslislyf, lausn 50 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

flúoróúracil accord stungulyf/innrennslislyf, lausn 50 mg/ml

accord healthcare b.v. - fluorouracilum inn - stungulyf/innrennslislyf, lausn - 50 mg/ml

Warfarin Teva Tafla 1 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

warfarin teva tafla 1 mg

teva b.v.* - warfarinum natríum - tafla - 1 mg

Rimactan Hart hylki 300 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

rimactan hart hylki 300 mg

sandoz gmbh* - rifampicinum inn - hart hylki - 300 mg

Rimactan Hart hylki 150 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

rimactan hart hylki 150 mg

sandoz gmbh* - rifampicinum inn - hart hylki - 150 mg

Atarax Mixtúra, lausn 2 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

atarax mixtúra, lausn 2 mg/ml

ucb nordic a/s - hydroxyzinum hýdróklóríð - mixtúra, lausn - 2 mg/ml

Warfarin Teva Tafla 3 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

warfarin teva tafla 3 mg

teva b.v.* - warfarinum natríum - tafla - 3 mg

Zavicefta Evrópusambandið - íslenska - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - sýklalyf fyrir almenn nota, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.